Markets:

Overview

News

Currencies

International

Treasuries

ProShares Ultra Nasdaq Biotechnology (NQ:BIB)

81.02 -5.25 (-6.09%)

Streaming Delayed Price Updated: 3:07 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ProShares Ultra Nasdaq Biotechnology

How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year ↗

December 24, 2025

A 1,900% rally, Phase 3 wins, and takeover chatter around Eli Lilly have transformed Abivax from a risky clinical bet into a strategic asset with real optionality.

Via Stocktwits

Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally ↗

October 17, 2025

Wedbush’s new price target implies a whopping 730% potential upside to the stock’s closing price on Thursday.

Via Stocktwits

Pharma Tariffs Back In Spotlight On New Trump Threat ↗

September 26, 2025

President Donald Trump threatened 100% tariffs on some drug imports.

Via Investor's Business Daily

Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn ↗

July 16, 2025

President Donald Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month.

Via Investor's Business Daily

Topics ETFs Government World Trade

Friday Trades And June Summary ↗

July 03, 2021

Trading performance has been very good year to date. I had thought I needed to tighten my belt but I made it by just fine.

Via Talk Markets

Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs ↗

July 08, 2025

President Donald Trump threatened Tuesday to levy up to 200% tariffs on drugs imported into the U.S. "very soon."

Via Investor's Business Daily

Topics ETFs Economy Government

Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals ↗

March 28, 2025

Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue...

Via Stocktwits

Topics Bankruptcy

Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility ↗

February 05, 2025

Short interest in the stock has grown steadily since mid-December, rising from 0.9% to 8.5% by the end of January, according to Koyfin data.

Via Stocktwits

Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding ↗

January 29, 2025

Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.

Via Stocktwits

Amgen, Inc. Dividend Stock Analysis ↗

July 05, 2024

Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.

Via Talk Markets

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗

March 25, 2024

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

Via InvestorPlace

The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities ↗

December 20, 2022

These are some of the best ETFs to buy heading into New Year 2023. Not only do they offer solid diversification, but they're cheap.

Via InvestorPlace

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond ↗

December 18, 2022

Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.

Via InvestorPlace

Market Briefing For Tuesday, July 5, 2022 ↗

July 04, 2022

This is a complicated time. Everything is bifurcated. Stocks. The political backdrop. Society itself.

Via Talk Markets

Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index ↗

December 17, 2021

Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ:

Via Benzinga

Take A Look At The Top-Performing Biotech ETFs YTD ↗

October 02, 2021

The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq...

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.